Efficacy of BBG-01 (Bifidobacterium breve) on pre and postoperative infectious complications of infants in Juntendo University Hospital

Efficacy of BBG-01 (Bifidobacterium breve) on pre and postoperative infectious complications of infants in Juntendo University Hospital - Efficacy of BBG-01 administration for infants

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005175

Enrollment

Registered

2011-03-03

Start date

2009-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric inpatients scheduled for gastrointestinal and urogenital surgery

Interventions

Bifidobacterium breve Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children less than 15 years old who will undergo operations at the Department of Pediatric General and Urogenital Surgery of Juntendo University Hospital

Exclusion criteria

Exclusion criteria: - A subject who cannot ingest the test diet due to intestinal dysfunction. - A subject whose operation is cancelled. - A subject who is not suitable for the trial defined by the attending researcher.

Design outcomes

Primary

Measure	Time frame
- Postoperative infectious complications - Sepsis - Intestinal microbiota - Gastrointestinal function	—

Secondary

Measure	Time frame
- Length of hospital stay - Blood biochemical indicators - Intestinal environment	—

Countries

Japan

Contacts

Public ContactTadaharu Okazaki

Juntendo University School of Medicine Department of Pediatric Surgery

okazakit@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026